Astellas Pharma has announced its intention to submit a planning application to build a new state-of-the-art facility, at an approximate cost of €330 million in Tralee, Co. Kerry.  This investment by Astellas in Ireland will expand their capacity and capabilities for aseptic drug products, reinforce stable production for global supply and accelerate the development and